{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T03:47:15Z","timestamp":1777693635469,"version":"3.51.4"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"Universit\u00e0 degli Studi di Siena (IT)"},{"name":"Toscana Life Sciences Foundation, Siena, ITALY"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Inform Decis Mak"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12911-017-0438-0","type":"journal-article","created":{"date-parts":[[2017,4,14]],"date-time":"2017-04-14T02:37:52Z","timestamp":1492137472000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["ApreciseKUre: an approach of Precision Medicine in a Rare Disease"],"prefix":"10.1186","volume":"17","author":[{"given":"Ottavia","family":"Spiga","sequence":"first","affiliation":[]},{"given":"Vittoria","family":"Cicaloni","sequence":"additional","affiliation":[]},{"given":"Andrea","family":"Bernini","sequence":"additional","affiliation":[]},{"given":"Andrea","family":"Zatkova","sequence":"additional","affiliation":[]},{"given":"Annalisa","family":"Santucci","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2017,4,14]]},"reference":[{"key":"438_CR1","unstructured":"National Institutes of Health. Precision Medicine Initiative Cohort Program. Precision Medicine Initiative Cohort Program\u2013Frequently Asked Questions. 2015. http:\/\/www.nih.gov\/precision-medicine-initiative-cohort-program . Accessed 6 Jul 2016."},{"key":"438_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/nature15816","author":"SJ Aronson","year":"2015","unstructured":"Aronson SJ, Rehm HL. Building the foundation for genomics in precision medicine. Nature. 2015. doi: 10.1038\/nature15816 .","journal-title":"Nature"},{"key":"438_CR3","unstructured":"European Commission, DG Research.Biomarkers for patient stratification. 2010. ec.europa.eu\/research\/health\/pdf\/biomarkers-for-patient-stratification_en.pdf.Accessed 2010."},{"issue":"4137","key":"438_CR4","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1016\/S0140-6736(01)41972-6","volume":"160","author":"AE Garrod","year":"1902","unstructured":"Garrod AE. The incidence of Alkaptonuria: a study in chemical individuality. Lancet. 1902;160(4137):1616\u201320.","journal-title":"Lancet"},{"issue":"2\u20133","key":"438_CR5","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0300-483X(00)00157-8","volume":"145","author":"ZL Hegedus","year":"2000","unstructured":"Hegedus ZL. The probable involvement of soluble and deposited melanins, their intermediates and the reactive oxygen side-products in human diseases and aging. Toxicology. 2000;145(2\u20133):85\u2013101.","journal-title":"Toxicology"},{"issue":"11","key":"438_CR6","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1016\/j.bbadis.2012.07.011","volume":"1822","author":"L Millucci","year":"2012","unstructured":"Millucci L, Spreafico A, Tinti L, Braconi D, Ghezzi L, Paccagnini E, Bernardini G, Amato L, Laschi M, Selvi E, Galeazzi M, Mannoni A, Benucci M, Lupetti P, Chellini F, Orlandini M, Santucci A. Alkaptonuria is a novel human secondary amyloidogenic disease. Biochim Biophys Acta. 2012;1822(11):1682\u201391.","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"438_CR7","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1136\/annrheumdis-2014-206033","volume":"75","author":"LR Ranganath","year":"2016","unstructured":"Ranganath LR, Milan AM, Hughes AT, Dutton JJ, Fitzgerald R, Briggs MC, Bygott H, Psarelli EE, Cox TF, Gallagher JA, Jarvis JC, van Kan C, Hall AK, Laan D, Olsson B, Szamosi J, Rudebeck M, Kullenberg T, Cronlund A, Svensson L, Junestrand C, Ayoob H, Timmis OG, Sireau N, Le Quan Sang KH, Genovese F, Braconi D, Santucci A, Nemethova M, Zatkova A, McCaffrey J, Christensen P, Ross G, Imrich R, Rovensky J. Suitability Of Nitisinone In Alkaptonuria 1 (SONIA 1): an international, multicentre, randomised, open-label, no-treatment controlled, parallel-group, dose-response study to investigate the effect of once daily nitisinone on 24-h urinary homogentisic acid excretion in patients with alkaptonuria after 4 weeks of treatment. Ann Rheum Dis. 2016;75(2):362\u20137.","journal-title":"Ann Rheum Dis"},{"key":"438_CR8","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/8904_2011_68","volume":"4","author":"A Zatkova","year":"2012","unstructured":"Zatkova A, Sedlackova T, Radvansky J, Polakova H, Nemethova M, Aquaron R, Dursun I, Usher JL, Kadasi L. Identification of 11 novel homogentisate 1,2 dioxygenase variants in alkaptonuria patients and establishment of a novel LOVD-based HGD mutation database. JIMD Rep. 2012;4:55\u201365.","journal-title":"JIMD Rep"},{"issue":"7","key":"438_CR9","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1080\/00365519850186210","volume":"25","author":"E Randers","year":"1998","unstructured":"Randers E, Kristensen JH, Erlandsen EJ, Danielsen H. Serum cystatin C as a marker of the renal function. Scand J Clin Lab Invest. 1998;25(7):585\u201392.","journal-title":"Scand J Clin Lab Invest"},{"issue":"6","key":"438_CR10","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.clinbiochem.2006.03.017","volume":"39","author":"A Ognibene","year":"2006","unstructured":"Ognibene A, Mannucci E, Caldini A, Terreni A, Brogi M, Bardini G, Sposato I, Mosconi V, Salvadori B, Rotella CM, Messeri G. Cystatin C reference values and aging. Clin Biochem. 2006;39(6):658\u201361.","journal-title":"Clin Biochem"},{"issue":"13\u201314","key":"438_CR11","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.clinbiochem.2007.05.011","volume":"40","author":"MT Croda-Todd","year":"2007","unstructured":"Croda-Todd MT, Soto-Montano XJ, Hern\u00e1ndez-Cancino PA, Ju\u00e1rez-Aguilar E. Adult cystatin C reference intervals determined by nephelometric immunoassay. Clin Biochem. 2007;40(13\u201314):1084\u20137.","journal-title":"Clin Biochem"},{"issue":"2","key":"438_CR12","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.4172\/0974-8369.1000206","volume":"6","author":"Z Khalkhali-Ellis","year":"2014","unstructured":"Khalkhali-Ellis Z, Hendrix Mary JC. Two faces of cathepsin D: physiological guardian angel and pathological demon. Biol Med (Aligarh). 2014;6(2):1206.","journal-title":"Biol Med (Aligarh)"},{"issue":"2","key":"438_CR13","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0014-5793(91)80295-E","volume":"280","author":"B Lenar\u010di\u010d","year":"1991","unstructured":"Lenar\u010di\u010d B, Kra\u0161ovec M, Ritonja A, Olafsson I, Turk V. Inactivation of human cystatin C and kininogen by human cathepsin D. FEBS Lett. 1991;280(2):211\u20135.","journal-title":"FEBS Lett"},{"key":"438_CR14","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1093\/ckj\/sfs079","volume":"5","author":"B Faria","year":"2012","unstructured":"Faria B, Vidinha J, P\u00eago C, Correia H, Sousa T. Clinical report: impact of chronic kidney disease on the natural history of alkaptonuria. Clin Kidney J. 2012;5:352\u20135.","journal-title":"Clin Kidney J"},{"issue":"6","key":"438_CR15","doi-asserted-by":"crossref","first-page":"339","DOI":"10.5414\/CN108608","volume":"84","author":"F Wolff","year":"2015","unstructured":"Wolff F, Biaou I, Koopmansch C, Vanden Bossche M, Pozdzik A, Roumegu\u00e8re T, Cotton F. Renal and prostate stones composition in alkaptonuria: a case report. Clin Nephrol. 2015;84(6):339\u201342.","journal-title":"Clin Nephrol"},{"issue":"7\u20138","key":"438_CR16","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.clinbiochem.2013.12.016","volume":"47","author":"SL Curtis","year":"2014","unstructured":"Curtis SL, Roberts NB, Ranganath LR. Interferences of homogentisic acid (HGA) on routine clinical chemistry assays in serum and urine and the implications for biochemical monitoring of patients with Alkaptonuria. Clin Biochem. 2014;47(7\u20138):640\u20137.","journal-title":"Clin Biochem"}],"container-title":["BMC Medical Informatics and Decision Making"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12911-017-0438-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T10:51:59Z","timestamp":1498387919000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcmedinformdecismak.biomedcentral.com\/articles\/10.1186\/s12911-017-0438-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,14]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["438"],"URL":"https:\/\/doi.org\/10.1186\/s12911-017-0438-0","relation":{},"ISSN":["1472-6947"],"issn-type":[{"value":"1472-6947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,14]]},"article-number":"42"}}